• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

OT wins Neal Award for Best News Coverage

Article

Ophthalmology Times was awarded Best News Coverage status at the 58th annual Jesse H. Neal National Business Journalism Awards competition recognizing editorial excellence. The awards were announced and presented March 16 at a ceremony at the Mandarin Oriental in New York City.

New York-Ophthalmology Times was awarded Best News Coverage status at the 58th annual Jesse H. Neal National Business Journalism Awards competition recognizing editorial excellence. The awards were announced and presented March 16 at a ceremony at the Mandarin Oriental in New York City.

Ophthalmology Times won a Neal Award for its reporting of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) results and the reaction following the announcement of those results. Honored were contributing editors Lynda Charters and Jennifer A. Webb, along with Peter J. McDonnell, MD, chief medical editor; Mark L. Dlugoss, group editor; Sheryl Stevenson, senior managing editor; and Helen Thams, associate editor.

The awards, sponsored by American Business Media, are regarded as the most prestigious honor that can be bestowed in business-to-business journalism, and often are referred to as the “Pulitzer Prize of the business media.” The competition is named after the association’s first managing director, Jesse H. Neal.

The multiple-article coverage appeared on Page 1 of the May 15, June 1, and Oct. 1, 2011 issues of Ophthalmology Times.

“We appreciate this important recognition,” said Peter J. McDonnell, MD, director of the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, and chief medical editor of Ophthalmology Times. “These articles deal with a very important, complex, and somewhat controversial study with potentially far-reaching implications. Ophthalmology Times endeavors to provide ophthalmologists with the most timely updates and news items that have implications for our practices.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.